Showing results (141-150 of 206) with videos related to

Sort By:
Pageof 21
Leukemia & Lymphoma|August 27, 2021
Treatment outcomes for patients with myelodysplastic syndrome/myeloproliferative neoplasms with ring sideroblasts and thrombocytosisRami Komrokji, Megan Melody, Najla Al Ali, et al.
Ebiomedicine|May 6, 2018
Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating AgentsMatthieu Duchmann, Fevzi F Yalniz, Alessandro Sanna, et al.
Leukemia|September 13, 2018
Downregulating Notch counteracts KrasGuangyao Kong, Xiaona You, Zhi Wen, et al.
Blood Advances|January 3, 2024
Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AMLOnyee Chan, Najla Al Ali, Hammad Tashkandi, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 9, 2017
TP53 and IDH2 Somatic Mutations Are Associated With Inferior Overall Survival After Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic SyndromeMohamed A Kharfan-Dabaja, Rami S Komrokji, Qing Zhang, et al.
Leukemia Research|November 8, 2021
MYC overexpression is associated with an early disease progression from MDS to AMLDavid Gajzer, Constantine N Logothetis, David A Sallman, et al.
The Lancet. Oncology|December 9, 2016
Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control studyNancy K Gillis, Markus Ball, Qing Zhang, et al.
Leukemia Research|February 12, 2025
Characteristics and survival outcomes of patients with myelodysplastic syndromes with isolated 11q deletionKensuke Takaoka, Rami Komrokji, Kelly Chien, et al.
Cancer|November 21, 2014
Outcome of patients with low-risk and intermediate-1-risk myelodysplastic syndrome after hypomethylating agent failure: a report on behalf of the MDS Clinical Research ConsortiumElias J Jabbour, Guillermo Garcia-Manero, Paolo Strati, et al.
Blood|November 6, 2016
p53-/- synergizes with enhanced NrasG12D signaling to transform megakaryocyte-erythroid progenitors in acute myeloid leukemiaJingfang Zhang, Guangyao Kong, Adhithi Rajagopalan, et al.
Pageof 21